Publications

Found 40 results
Filters: First Letter Of Last Name is R  [Clear All Filters]
2022
Jarick KJ, Topczewska PM, Jakob MO, Yano H, Arifuzzaman M, Gao X, Boulekou S, Stokic-Trtica V, Leclère PS, Preußer A et al..  2022.  Non-redundant functions of group 2 innate lymphoid cells.. Nature. 611(7937):794-800.
Jarick KJ, Topczewska PM, Jakob MO, Yano H, Arifuzzaman M, Gao X, Boulekou S, Stokic-Trtica V, Leclère PS, Preußer A et al..  2022.  Non-redundant functions of group 2 innate lymphoid cells.. Nature. 611(7937):794-800.
2023
Wheeler MA, Clark IC, Lee H-G, Li Z, Linnerbauer M, Rone JM, Blain M, Akl CFaust, Piester G, Giovannoni F et al..  2023.  Droplet-based forward genetic screening of astrocyte-microglia cross-talk.. Science. 379(6636):1023-1030.
Wheeler MA, Clark IC, Lee H-G, Li Z, Linnerbauer M, Rone JM, Blain M, Akl CFaust, Piester G, Giovannoni F et al..  2023.  Droplet-based forward genetic screening of astrocyte-microglia cross-talk.. Science. 379(6636):1023-1030.
2024
Liao Y, Gao IH, Kusakabe T, Lin W-Y, Grier A, Pan X, Morzhanaeva O, Shea TP, Yano H, Karo-Atar D et al..  2024.  Fungal symbiont transmitted by free-living mice promotes type 2 immunity.. Nature. 636(8043):697-704.
Troch KF, Jakob MO, Forster PM, Jarick KJ, Schreiber J, Preusser A, Guerra GM, Durek P, Tizian C, Sterczyk N et al..  2024.  Group 2 innate lymphoid cells are a non-redundant source of interleukin-5 required for development and function of murine B1 cells.. Nat Commun. 15(1):10566.
Kim B, Rothenberg ME, Sun X, Bachert C, Artis D, Zaheer R, Deniz Y, Rowe P, Cyr S.  2024.  Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases.. J Allergy Clin Immunol. 153(4):879-893.
Kim B, Rothenberg ME, Sun X, Bachert C, Artis D, Zaheer R, Deniz Y, Rowe P, Cyr S.  2024.  Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases.. J Allergy Clin Immunol. 153(4):879-893.
2025
Rao S, Azuero-Dajud R, Lorman V, Landeo-Gutierrez J, Rhee KE, Ryu J, Kim C, Carmilani M, Gross RS, Mohandas S et al..  2025.  Ethnic and racial differences in children and young people with respiratory and neurological post-acute sequelae of SARS-CoV-2: an electronic health record-based cohort study from the RECOVER Initiative.. EClinicalMedicine. 80:103042.
Rao S, Azuero-Dajud R, Lorman V, Landeo-Gutierrez J, Rhee KE, Ryu J, Kim C, Carmilani M, Gross RS, Mohandas S et al..  2025.  Ethnic and racial differences in children and young people with respiratory and neurological post-acute sequelae of SARS-CoV-2: an electronic health record-based cohort study from the RECOVER Initiative.. EClinicalMedicine. 80:103042.
Rao S, Azuero-Dajud R, Lorman V, Landeo-Gutierrez J, Rhee KE, Ryu J, Kim C, Carmilani M, Gross RS, Mohandas S et al..  2025.  Ethnic and racial differences in children and young people with respiratory and neurological post-acute sequelae of SARS-CoV-2: an electronic health record-based cohort study from the RECOVER Initiative.. EClinicalMedicine. 80:103042.
Rao S, Azuero-Dajud R, Lorman V, Landeo-Gutierrez J, Rhee KE, Ryu J, Kim C, Carmilani M, Gross RS, Mohandas S et al..  2025.  Ethnic and racial differences in children and young people with respiratory and neurological post-acute sequelae of SARS-CoV-2: an electronic health record-based cohort study from the RECOVER Initiative.. EClinicalMedicine. 80:103042.
Rao S, Azuero-Dajud R, Lorman V, Landeo-Gutierrez J, Rhee KE, Ryu J, Kim C, Carmilani M, Gross RS, Mohandas S et al..  2025.  Ethnic and racial differences in children and young people with respiratory and neurological post-acute sequelae of SARS-CoV-2: an electronic health record-based cohort study from the RECOVER Initiative.. EClinicalMedicine. 80:103042.
Amisaki M, Zebboudj A, Yano H, Zhang SLinsey, Payne G, Chandra AKaya, Yu R, Guasp P, Sethna ZM, Ohmoto A et al..  2025.  IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer.. Nature.
Amisaki M, Zebboudj A, Yano H, Zhang SLinsey, Payne G, Chandra AKaya, Yu R, Guasp P, Sethna ZM, Ohmoto A et al..  2025.  IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer.. Nature.